臨床試驗

Early Feasibility Study of 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation

NCT：NCT07811609 · NOT_YET_RECRUITING

NCT IDNCT07811609

狀態NOT_YET_RECRUITING

SponsorMinneapolis Heart Institute Foundation (OTHER)

First posted2026-09-10

Last updated2026-09-10

簡要摘要

Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3930M Lead when implanted via the Middle Cardiac Vein in patients with Tricuspid Valve Regurgitation

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。